Park Medi World · NSE: PARKHOSPS · BSE: 544645
Q4 FY26 results · Jan–Mar 2026
Park Medi World reported revenue from operations of ₹460.41 crore and net profit of ₹76.78 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 460.41 | — | — | 409.97 | +12.3% |
| Other income | 7.50 | — | — | 9.10 | −17.6% |
| Total income | 467.92 | — | — | 419.07 | +11.7% |
| Profit before tax | 103.39 | — | — | 78.27 | +32.1% |
| Net profit for the period | 76.78 | — | — | 52.85 | +45.3% |
| Attributable to shareholders of the company | 70.86 | — | — | 50.78 | +39.6% |
| EPS, basic (₹) | 1.78 | — | — | 1.35 | +31.9% |
| Net margin (%) | 16.7 | — | 12.9 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 27.43 | — | — | 45.87 | −40.2% |
| Other income | 8.27 | — | — | 5.52 | +49.9% |
| Total income | 35.70 | — | — | 51.39 | −30.5% |
| Profit before tax | 9.61 | — | — | 18.75 | −48.7% |
| Net profit for the period | 8.61 | — | — | 14.56 | −40.9% |
| EPS, basic (₹) | 0.20 | — | — | 0.37 | −45.9% |
| Net margin (%) | 31.4 | — | 31.7 |
Consolidated
- Filed with BSE
- 12 May 2026, 16:28 IST
- Board meeting
- 12 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 May 2026, 16:28 IST
- Board meeting
- 12 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE